サマリー

ペプチド治療薬の世界市場 2022-2026 年
Technavioはペプチド治療薬市場を監視しており、2022-2026年の間に233億6000万ドルの成長が見込まれ、予測期間中にCAGR 12.52%で加速しています。当レポートでは、ペプチド治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、感染症の蔓延、有利な償還政策の利用可能性、半減期が延長された薬剤によって牽引されています。
ペプチド治療薬市場の分析には、投与経路セグメントと地理的展望が含まれます。
Technavioのペプチド治療薬市場は、以下のように区分されています。
投与経路別
- 非経口
- 経口
- その他
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、研究開発のための共同研究が、今後数年間のペプチド治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、ペプチド治療薬の強力なパイプラインと新規技術の出現は、市場の大規模な需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ペプチド治療薬市場に関する当レポートは、以下の分野を対象としています。
- ペプチド治療薬市場のサイジング
- ペプチド治療薬市場の予測
- ペプチド治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Almac Group Ltd., AmbioPharm Inc, Amgen Inc,AstraZeneca Plc、Bachem AG、Bristol Myers Squibb Co.、Corden Pharma International GmbH、Eli Lilly and Co.、Ever Pharma、F. Hoffmann La Roche Ltd、GlaxoSmithKline Plc、Ipsen Pharma、Lonza Group Ltd.、Novartis AG、Novo Nordisk AS、PeptiDream Inc、Pfizer Inc、PolyPeptide Group、Sanofi、Takeda Pharmaceutical Co.Ltd.、Teva Pharmaceutical Industries Ltd.、Wrong pharmaの6社です。また、ペプチド治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/peptide-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Parenteral - Market size and forecast 2021-2026
o Exhibit 28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
o 5.4 Oral - Market size and forecast 2021-2026
o Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Route of Administration
o Exhibit 40: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 89: Amgen Inc. - Overview
o Exhibit 90: Amgen Inc. - Product / Service
o Exhibit 91: Amgen Inc. - Key offerings
o 10.4 AstraZeneca Plc
o Exhibit 92: AstraZeneca Plc - Overview
o Exhibit 93: AstraZeneca Plc - Product / Service
o Exhibit 94: AstraZeneca Plc - Key news
o Exhibit 95: AstraZeneca Plc - Key offerings
o 10.5 Eli Lilly and Co.
o Exhibit 96: Eli Lilly and Co. - Overview
o Exhibit 97: Eli Lilly and Co. - Product / Service
o Exhibit 98: Eli Lilly and Co. - Key offerings
o 10.6 Ever Pharma
o Exhibit 99: Ever Pharma - Overview
o Exhibit 100: Ever Pharma - Product / Service
o Exhibit 101: Ever Pharma - Key offerings
o 10.7 GlaxoSmithKline Plc
o Exhibit 102: GlaxoSmithKline Plc - Overview
o Exhibit 103: GlaxoSmithKline Plc - Business segments
o Exhibit 104: GlaxoSmithKline Plc - Key news
o Exhibit 105: GlaxoSmithKline Plc - Key offerings
o Exhibit 106: GlaxoSmithKline Plc - Segment focus
o 10.8 Novo Nordisk AS
o Exhibit 107: Novo Nordisk AS - Overview
o Exhibit 108: Novo Nordisk AS - Business segments
o Exhibit 109: Novo Nordisk AS - Key offerings
o Exhibit 110: Novo Nordisk AS - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 111: Pfizer Inc. - Overview
o Exhibit 112: Pfizer Inc. - Product / Service
o Exhibit 113: Pfizer Inc. - Key news
o Exhibit 114: Pfizer Inc. - Key offerings
o 10.10 Sanofi
o Exhibit 115: Sanofi - Overview
o Exhibit 116: Sanofi - Business segments
o Exhibit 117: Sanofi - Key news
o Exhibit 118: Sanofi - Key offerings
o Exhibit 119: Sanofi - Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 126: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 129: Inclusions checklist
o Exhibit 130: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 131: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 132: Research methodology
o Exhibit 133: Validation techniques employed for market sizing
o Exhibit 134: Information sources
o 11.5 List of abbreviations
o Exhibit 135: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Route of Administration ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Amgen Inc. - Overview
Exhibits90: Amgen Inc. - Product / Service
Exhibits91: Amgen Inc. - Key offerings
Exhibits92: AstraZeneca Plc - Overview
Exhibits93: AstraZeneca Plc - Product / Service
Exhibits94: AstraZeneca Plc - Key news
Exhibits95: AstraZeneca Plc - Key offerings
Exhibits96: Eli Lilly and Co. - Overview
Exhibits97: Eli Lilly and Co. - Product / Service
Exhibits98: Eli Lilly and Co. - Key offerings
Exhibits99: Ever Pharma - Overview
Exhibits100: Ever Pharma - Product / Service
Exhibits101: Ever Pharma - Key offerings
Exhibits102: GlaxoSmithKline Plc - Overview
Exhibits103: GlaxoSmithKline Plc - Business segments
Exhibits104: GlaxoSmithKline Plc - Key news
Exhibits105: GlaxoSmithKline Plc - Key offerings
Exhibits106: GlaxoSmithKline Plc - Segment focus
Exhibits107: Novo Nordisk AS - Overview
Exhibits108: Novo Nordisk AS - Business segments
Exhibits109: Novo Nordisk AS - Key offerings
Exhibits110: Novo Nordisk AS - Segment focus
Exhibits111: Pfizer Inc. - Overview
Exhibits112: Pfizer Inc. - Product / Service
Exhibits113: Pfizer Inc. - Key news
Exhibits114: Pfizer Inc. - Key offerings
Exhibits115: Sanofi - Overview
Exhibits116: Sanofi - Business segments
Exhibits117: Sanofi - Key news
Exhibits118: Sanofi - Key offerings
Exhibits119: Sanofi - Segment focus
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits123: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits124: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits125: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits126: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits127: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits128: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits129: Inclusions checklist
Exhibits130: Exclusions checklist
Exhibits131: Currency conversion rates for US$
Exhibits132: Research methodology
Exhibits133: Validation techniques employed for market sizing
Exhibits134: Information sources
Exhibits135: List of abbreviations